Search research articles
Contact Us
Filters
Showing results (151-160 of 635) with videos related to
Page
of 64
Sort By:
Journal of the American Society of Nephrology : JASN
|
September 19, 2019
Effect of Canagliflozin on Renal and Cardiovascular Outcomes across Different Levels of Albuminuria: Data from the CANVAS Program
Brendon L Neuen, Toshiaki Ohkuma, Bruce Neal, et al.
European Heart Journal
|
May 6, 2005
Prognostic significance of blood markers of inflammation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty and effects of pexelizumab, a C5 inhibitor: a substudy of the COMMA trial
Pierre Théroux, Paul W Armstrong, Kenneth W Mahaffey, et al.
Trials
|
June 21, 2013
Methods of creatine kinase-MB analysis to predict mortality in patients with myocardial infarction treated with reperfusion therapy
Renato D Lopes, Yuliya Lokhnygina, Victor Hasselblad, et al.
American Heart Journal
|
December 21, 2018
Characterization of cardiovascular clinical events and impact of event adjudication on the treatment effect of darapladib versus placebo in patients with stable coronary heart disease: Insights from the STABILITY trial
Claes Held, Harvey D White, Ralph A H Stewart, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
January 22, 2022
Potential Effects of Elimination of the Black Race Coefficient in eGFR Calculations in the CREDENCE Trial
David M Charytan, Jie Yu, Meg J Jardine, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
August 12, 2025
Deep Learning Chest X-Ray Age, Epigenetic Aging Clocks and Associations with Age-Related Subclinical Disease in the Project Baseline Health Study
Jay Chandra, Sarah Short, Fatima Rodriguez, et al.
American Heart Journal
|
July 31, 2013
Results of a reevaluation of cardiovascular outcomes in the RECORD trial
Kenneth W Mahaffey, Gail Hafley, Sheila Dickerson, et al.
Trials
|
April 11, 2020
Methods for safety and endpoint ascertainment: identification of adverse events through scrutiny of negatively adjudicated events
Alexander C Fanaroff, Ghazala Haque, Betsy Thomas, et al.
Circulation
|
March 13, 2018
Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program
Karin Rådholm, Gemma Figtree, Vlado Perkovic, et al.
European Journal of Clinical Investigation
|
May 28, 2011
Determinants of plasma vitamin D levels in patients with acute coronary syndromes
Gabriella Rodriguez, Aijing Z Starr, Grazyna Z Czernuszewicz, et al.
Page
of 64
Search research articles
Search
Showing results (151-160 of 635) with videos related to
Sort By:
Page
of 64
Journal of the American Society of Nephrology : JASN
|
September 19, 2019
Effect of Canagliflozin on Renal and Cardiovascular Outcomes across Different Levels of Albuminuria: Data from the CANVAS Program
Brendon L Neuen, Toshiaki Ohkuma, Bruce Neal, et al.
European Heart Journal
|
May 6, 2005
Prognostic significance of blood markers of inflammation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty and effects of pexelizumab, a C5 inhibitor: a substudy of the COMMA trial
Pierre Théroux, Paul W Armstrong, Kenneth W Mahaffey, et al.
Trials
|
June 21, 2013
Methods of creatine kinase-MB analysis to predict mortality in patients with myocardial infarction treated with reperfusion therapy
Renato D Lopes, Yuliya Lokhnygina, Victor Hasselblad, et al.
American Heart Journal
|
December 21, 2018
Characterization of cardiovascular clinical events and impact of event adjudication on the treatment effect of darapladib versus placebo in patients with stable coronary heart disease: Insights from the STABILITY trial
Claes Held, Harvey D White, Ralph A H Stewart, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
January 22, 2022
Potential Effects of Elimination of the Black Race Coefficient in eGFR Calculations in the CREDENCE Trial
David M Charytan, Jie Yu, Meg J Jardine, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
August 12, 2025
Deep Learning Chest X-Ray Age, Epigenetic Aging Clocks and Associations with Age-Related Subclinical Disease in the Project Baseline Health Study
Jay Chandra, Sarah Short, Fatima Rodriguez, et al.
American Heart Journal
|
July 31, 2013
Results of a reevaluation of cardiovascular outcomes in the RECORD trial
Kenneth W Mahaffey, Gail Hafley, Sheila Dickerson, et al.
Trials
|
April 11, 2020
Methods for safety and endpoint ascertainment: identification of adverse events through scrutiny of negatively adjudicated events
Alexander C Fanaroff, Ghazala Haque, Betsy Thomas, et al.
Circulation
|
March 13, 2018
Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program
Karin Rådholm, Gemma Figtree, Vlado Perkovic, et al.
European Journal of Clinical Investigation
|
May 28, 2011
Determinants of plasma vitamin D levels in patients with acute coronary syndromes
Gabriella Rodriguez, Aijing Z Starr, Grazyna Z Czernuszewicz, et al.
Page
of 64